NCT00785512 - A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy | Biotech Hunter

Enrollment

207

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2009

Conditions

Hypertension

Interventions

DRUG

Nebivolol

Nebivolol 10 mg, 10-mg Nebivolol nontrade tablets , oral administration Nebivolol 20 mg, 20-mg Nebivolol nontrade tablets , oral administration Nebivolol 40 mg, two 20-mg Nebivolol nontrade tablets , oral administration

DRUG

Placebo

Matching placebo tablets, oral administration

Trial Locations (26)

17601

Forest Investigative Site, Lancaster

27103

Forest Investigative Site, Winston-Salem

27518

Forest Investigative Site, Cary

28144

Forest Investigative Site, Salisbury

28401

Forest Investigative Site, Wilmington

28601

Forest Investigative Site, Hickory

29464

Forest Investigative Site, Mt. Pleasant

29681

Forest Investigative Site, Simpsonville

32720

Forest Investigative Site, DeLand

33014

Forest Investigative Site, Miami

33021

Forest Investigative Site, Hollywood

33024

Forest Investigative Site, Pembroke Pines

33156

Forest Investigative Site, Miami

33169

Forest Investigative Site, Miami

33709

Forest Investigative Site, St. Petersburg

34203

Forest Investigative Site, Bradenton

34613

Forest Investigative Site, Brooksville

37825

Forest Investigative Site, New Tazewell

43302

Forest Investigative Site, Marion

45242

Forest Investigative Site, Cincinnati

75231

Forest Investigative Site, Dallas

75234

Forest Investigative Site, Dallas

85050

Forest Investigative Site, Phoenix

85225

Forest Investigative Site, Chandler

90057

Forest Investigative Site, Los Angeles

04210

Forest Investigative Site, Auburn